Amgen stock consolidates near $348 amid robust Research Triangle growth

Traders Union
All News
Companies
Amgen drops 0.78% to $347.78 today

Highlights

AMGN maintains a bullish structure, trading above key long-term and short-term moving averages despite a 2% weekly pullback.
Momentum signals are mixed, with overbought pressure evident and trend strength indicators remaining subdued, suggesting possible consolidation.
Next week's projected price range is $343.33–$349.99, with an 80%+ likelihood of sideways-to-upside movement unless support at $339.72 fails.

Bullish alignment as price holds above clustered moving supports

AMGN is trading at $347.78, above the MA-20 ($339.37), MA-50 ($340.35), and MA-200 ($331.04), which confirms a bullish structure for short-, medium-, and long-term trends. The Ichimoku Kijun on D1 is $339.72, representing immediate support below the current price. Near-term support levels are clustered at MA-50 ($340.35) and Ichimoku Kijun ($339.72), while key support is at MA-200 ($331.04). Resistance appears at MA-100 ($351.75) as near-term and MA-5 EMA ($349.32) as key resistance.

Mixed momentum as overbought signals offset weak trend strength

Momentum remains mixed, with MACD on D1 giving a buy signal while ADX indicates a weak trend. RSI and CCI both suggest some overbought pressure, and Stoch RSI on D1 points to strong selling, highlighting a divergence among oscillators. The BBP is in overbought territory, signaling recent buyer dominance, which is somewhat contradicted by HMA, which gives a sell signal. AMGN has fallen $7.39 (2.08%) over the past week, down from the previous week's close of $355.17, with current price sitting in the middle of the weekly range. Weekly volatility stands at 6.21%, with the recent movement suggesting mild consolidation after a steady retracement from near the weekly high.

Strong upside bias as consolidation underpins breakout potential

Looking ahead, the expected range for the coming week is $343.33 to $349.99, slightly above the midpoint of the 52-week span ($267.83–$391.29). The probability of a price increase is at the maximum, so there is a very high probability (more than 80%) of upside movement, while the likelihood of a decline is very low. The baseline scenario projects AMGN stabilizing within a narrow sideways corridor near recent levels. A bullish scenario would see a breakout above resistance at $351.75, targeting the higher end of the projected range. Conversely, a bearish scenario would be triggered if support at $339.72 fails, opening the path toward the lower end of the weekly forecast.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Previously it was reported that Amgen was consolidating with institutional inflows and clinical progress offering potential upside catalysts. In light of current developments, investors should closely monitor for a decisive close above recent resistance, which could signal the next directional move for the stock.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.